RecruitingPhase 4NCT05080569
Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment
LUMO Study: Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH
Sponsor
UMC Utrecht
Enrollment
1,008 participants
Start Date
Mar 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The LUMO study is a multicenter, randomized controlled trial that evaluates the effectivity of luteal phase support in MOH/IUI treatment.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria8
- Couples starting IUI with Mild Ovarian HyperStimulation (MOH), with the intend to receive this treatment for at least six months.
- Diagnosis of unexplained (primary or secondary) infertility
- Hunault <30% (or >30%, after an expectant management period of at least 6 additional months).
- Females aged >18 years with regular menstrual cycle.
- Total mobile sperm count (VCM) >10 million.
- Exclusion cirteria:
- Cycle irregularities
- Male factor infertility
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGProgesterone Vaginal Product
3dd200mg
DRUGPlacebo
3dd1 vaginal capsule
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05080569
Related Trials
Advanced Wireless Sensors for Neonatal Care in the Delivery Room
NCT066938175 locations
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
NCT054509781 location
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
NCT061581261 location
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
NCT065815361 location
The Lullaby Project as a Musical Intervention for Pregnant Individuals With Epilepsy
NCT055032901 location